Hi-D Imaging 4TAVR vs Tempus ECG-AF
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, Hi-D Imaging 4TAVR, is designed for pre-procedural planning of Transcatheter Aortic Valve Replacement (TAVR) by providing automated measurements from imaging data. Tool B, Tempus ECG-AF, focuses on analyzing 12-lead ECGs to identify patients at increased risk of developing atrial fibrillation. While both are FDA-cleared AI tools in cardiology, they address distinct clinical applications: surgical planning versus risk assessment for a specific arrhythmia.
Choose Hi-D Imaging 4TAVR if…
Choose Hi-D Imaging 4TAVR if your cardiology department requires a highly efficient, AI-powered solution for pre-procedural Transcatheter Aortic Valve Replacement (TAVR) planning. This tool is ideal for streamlining workflows by providing fully automated measurements, segmentation, and 2D/3D reconstructed images, ensuring fast and reproducible case evaluations for complex TAVR procedures.
View Hi-D Imaging 4TAVR →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your clinic focuses on identifying at-risk patients for new-onset Atrial Fibrillation (AF) within the next 12 months, particularly those aged 65 or older. This AI-based algorithm is best suited for integrating with existing 12-lead ECG systems to proactively screen and support earlier identification and follow-up for AF, enhancing preventative cardiology efforts.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Hi-D Imaging 4TAVR | Tempus ECG-AF |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor |
| Deployment | Cloud (SaaS) | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Hi-D Imaging 4TAVR | Tempus ECG-AF |
|---|---|---|
| Name | Hi-D Imaging 4TAVR | Tempus ECG-AF |
| Primary Function | Provides fully automated measurements for pre-procedural Transcatheter Aortic Valve Replacement (TAVR) planning. | Analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Company | Hi-D Imaging AG | Tempus AI, Inc. |
| Key AI Application | AI-powered automated measurements for TAVR planning, fully automated segmentation, automated centerline-based MPR planes. | AI-based algorithm for 12-lead ECG analysis to detect signs associated with new onset Atrial Fibrillation (AF). |
| Target Patient Population/Use Case | Pre-procedural TAVR planning. | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, for identifying risk of AF within 12 months. |
Videos
Demos, reviews, and walkthroughs featuring Hi-D Imaging 4TAVR and Tempus ECG-AF.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Hi-D Imaging 4TAVR is a cloud-based SaaS platform that provides fully automated measurements for TAVR planning, aiming to streamline clinical workflows and enhance decision-making. It offers a one-click solution for image upload and analysis, generating 2D and 3D reconstructed images and clinically-relevant parameters for fast and reproducible case evaluations.
Tempus ECG-AF integrates into healthcare facility systems to analyze 12-lead ECGs, identifying patients aged 65 or older at increased risk of developing AF within 12 months. A positive result indicates an increased risk and should prompt clinicians to consider further follow-up to detect AF, interpreting results in conjunction with other diagnostic information and clinical history.
Hi-D Imaging 4TAVR aims for accurate, reproducible, and fast case evaluations by automating measurements for TAVR planning, validated in clinical studies. Tempus ECG-AF, trained on over 1.5 million ECGs, demonstrated a sensitivity of 31% and specificity of 92% for classifying patients who developed clinically recognized AF within one year in a retrospective study.
Hi-D Imaging 4TAVR is a cloud-based SaaS platform with a 'one-click solution' for image upload and analysis, suggesting integration points for image transfer and report generation. Tempus ECG-AF is a software solution integrated into healthcare facility systems, with Tempus focusing on partnerships with EHR providers to ensure seamless implementation for automated ECG data ingestion and result output.
Hi-D Imaging 4TAVR emphasizes a 'one-click solution' and 'no training requirement' for its cloud-based platform, suggesting a low learning curve and rapid realization of workflow efficiencies. Tempus ECG-AF, while integrating into existing systems, requires clinicians to understand its specific patient criteria and integrate its risk stratification into clinical pathways, with the goal of earlier disease identification and management.
Hi-D Imaging 4TAVR states its products are developed with the highest security standards, with regular, automatic updates. Tempus safeguards data through a defense-in-depth security strategy, including rigorous de-identification processes, high-level encryption for data in transit and at rest, strict access controls, and regular independent third-party audits.
While specific audit trail features for Hi-D Imaging 4TAVR are not detailed, as a cloud-based medical software, it would be expected to maintain logs of user interactions and analyses. Tempus ECG-AF, integrated into healthcare facility systems, would likely leverage existing EHR audit trails, which typically track user identification, timestamps, actions performed, and records affected to ensure accountability and transparency.
More Comparisons
More matchups featuring Hi-D Imaging 4TAVR or Tempus ECG-AF
Backers
Who funded each tool's parent company.